381) idamycin suppressed Huh7 tumor initiating cells via GSK3β/β-catenin pathway. |
382) ranslated to in vivo targeted delivery of cells via the circulation in a variety of |
383) n ideal method for identifying subsets of cells without the need for markers by usin |
384) of mouse induced pluripotent stem (miPS) cells without using feeder-cells and adhes |
385) Human adipose tissue-derived regenerative cells (ADRCs) can be isolated easily and a |
386) ted human amniotic fluid mesenchymal stem cells (AFMSCs) as feeder cells to support |
387) uman bone marrow-derived mesenchymal stem cells (BM-MSCs) and human adipose tissue-d |
388) NKL) signaling helps putative cancer stem cells (CSC) to maintain their stemness. |
389) on's jelly (WJ) MSCs and dental pulp stem cells (DPSCs) were highly proliferative as |
390) ne or CMs with surface-seeded endothelial cells (ECs; CM/EC modules) were injected i |
391) e the potential of human endometrial stem cells (EnSCs) to form urinary bladder epit |
392) the cellular behaviour of hepatocyte-like cells (HLCs) on the surface of the galacto |
393) For SaBP, human mesenchymal stem cells (HMSCs), umbilical cord vein endothe |
394) Oral keratinocyte cells (HaCaT) were exposed to 25 μM alen |
395) proliferation of intermediate progenitor cells (IPCs) was affected. |
396) saline (PBS) and bone marrow mononuclear cells (MNCs) were injected as negative and |
397) ntal and clinical use of mesenchymal stem cells (MSCs), focusing mainly on the treat |
398) dvantages of menstrual blood-derived stem cells (MenSCs), such as minimal ethical co |
399) The cell viability of injected cells (NPCs or hMSCs) was maintained at ov |
400) tion of co-transplanted neural progenitor cells (NPCs) and stimulate the plasticity |
401) nic differentiated human mesenchymal stem cells (O-hMSCs) to recruit MSCs. |
402) t-spiking (FS) interneurons and pyramidal cells (PCs) in prefrontal cortical slices |
403) loyed for modelling the flow of red blood cells (RBCs) in blood plasma. |
404) generation of vasculogenic smooth muscle cells (SMCs) from hPSCs have been describe |
405) ion and trauma, synovial mesenchymal stem cells (SMSCs) were used in this study as t |
406) transduced in a synovial mesenchymal stem cells (SMSCs)-based articular chondrogenic |
407) n the quantities of activated cytotoxic T-cells (TCTL; CD3(+)CD8(+)CD71(+)) and help |
408) Tumour-initiating cells (TICs) have been identified in many |
409) interaction through the adhesion of INS-1 cells (a rat insulinoma cell line) to CDPG |
410) matrices were used for suspending SaOS-2 cells: (a) the hydrogel alone; (b) the hyd |
411) cardiac adipose tissue-derived progenitor cells (cardiac ATDPCs). |
412) ls, phenotypically abnormal/dysfunctional cells (cellular burden) and bacteria seque |
413) nsplantation of ependymal stem/progenitor cells (epSPCs), which are spinal cord-deri |
|